Patents by Inventor Brendan J. Canning

Brendan J. Canning has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEUROMODULATION DEVICE
    Publication number: 20200009384
    Abstract: The invention provides devices and methods that can prevent or ameliorate bronchoconstriction. In particular, the invention provides devices and methods in which a signal is delivered to the vagus nerve or the pulmonary branches of the vagus nerves. The signal is able to treat bronchoconstriction and prevent and/or ameliorate bronchoconstriction.
    Type: Application
    Filed: September 5, 2019
    Publication date: January 9, 2020
    Inventors: Brendan J. CANNING, Michael John CARR, Marian KOLLARIK
  • Neuromodulation device
    Patent number: 10441787
    Abstract: The invention provides devices and methods that can prevent or ameliorate bronchoconstriction. In particular, the invention provides devices and methods in which a signal is delivered to the vagus nerve or the pulmonary branches of the vagus nerves. The signal is able to treat bronchoconstriction and prevent and/or ameliorate bronchoconstriction.
    Type: Grant
    Filed: February 24, 2016
    Date of Patent: October 15, 2019
    Assignees: GALVANI BIOELECTRONICS LIMITED, THE JOHNS HOPKINS UNIVERSITY
    Inventors: Brendan J. Canning, Michael John Carr, Marian Kollarik
  • NEUROMODULATION DEVICE
    Publication number: 20180043162
    Abstract: The invention provides devices and methods that can prevent or ameliorate bronchoconstriction. In particular, the invention provides devices and methods in which a signal is delivered to the vagus nerve or the pulmonary branches of the vagus nerves. The signal is able to treat bronchoconstriction and prevent and/or ameliorate bronchoconstriction.
    Type: Application
    Filed: February 24, 2016
    Publication date: February 15, 2018
    Inventors: BRENDAN J. CANNING, Michael John CARR, Marian KOLLARIK
  • Targeting the Alpha3 Subnit of Na+-K+-ATPase for the Treatment of Cough with Sulfenamides
    Publication number: 20130164386
    Abstract: Therapeutic agents that target the alpha3 expressing isozymes of the sodium pump at the peripheral terminals of cough receptors and methods of use thereof to prevent or treat cough are disclosed.
    Type: Application
    Filed: June 17, 2011
    Publication date: June 27, 2013
    Applicant: THE JOHNS HOPKINS UNIVERSITY
    Inventor: Brendan J. Canning